SUJA.L $523.13 0.8434%
CVGI $9.88 0.8163%
SNR.L $173.20 1.1682%
NKTX $4.50 0.5593%
EVG $9.74 -1.1168%
EMAD.L $65.87 -0.7459%
E40.PA $11.91 0.3032%
ABEO.PA $17.95 1.4124%
UCHF $23.56 0%
SLAMW $0.20 10.7718%
VBIV $2.86 -8.9172%
AWRE $1.66 0%
IART $49.03 -1.1492%
6168.HK $0.16 0%
FORH $23.82 0.8681%
GLHA $10.08 0%
GNE.NZ $2.73 0.1838%
PARI.L $32.48 -0.184374%
NTEC $9.63 0%
RMII.L $77.50 0%
EVRA.L $11.50 0%
SQSP $28.00 -0.2849%
BTMDW $1.29 7.5%
LIND $10.01 -6.3611%
DTM $46.78 0.3002%
ANIK $25.23 -0.3161%
TKAT $0.54 -4.8246%
EDBL $1.68 -7.6923%
MERY.PA $7.85 -1.3199%
MLPA $40.64 0.6564%
2281.HK $0.78 0%
NVSAU $10.15 0%
EURL $22.85 -0.609%
XDNG.L $1 919.50 1.5877%
BERY $57.13 -1.534%
MVV $45.96 -1.0159%
EWM $21.61 -1.0979%
AQSG.L $26.00 0%
GEDV.L $17.86 0.4952%
ALACW $0.01 0%
OFSSI $25.09 0%
CMS-PB $91.71 1.7192%
DVYE $24.89 -0.6784%
ALT $5.04 -5.4409%
PBT $24.19 -0.82%
GRP.IR $1.09 0%
MN $12.85 0%
0179.HK $8.46 -1.6279%
VBR $151.49 -0.6395%
VRE.L $18.45 0%
RLGY $12.08 0%
2186.HK $3.60 -1.0989%
KCE $78.04 -0.5448%
VCLN $22.12 0%
EM $0.90 -2.4607%
FTV-PA $983.01 0%
OBC.L $14.50 0%
U10C.L $7.55 -0.0132%
ALPCV.PA $3.00 3.4483%
MACA $10.33 0.0969%
ARNA $99.99 0%
VSCIX $88.12 -0.6091%
9804.HK $7.63 0%
HWKN $42.45 1.3491%
HLT.PA $140.99 0.6108%
DDV1.L $57.00 0%
0646.HK $0.53 -10.1695%
0KV3.L $15.55 -2.0355%
HP $31.07 0.4365%
LEGAU $10.21 0%
0780.HK $15.36 0.6553%
ARGUU $10.23 0%
3768.HK $0.96 -3.0303%
IGDA.L $21.57 -0.1274%
WOMN $28.17 -0.5244%
0662.HK $3.40 0%
KSTR $15.30 -2.2988%
TSCPX $9.99 -0.498%
DGS $45.56 -0.8703%
ALNA $0.08 0%
USIM3.SA $7.17 -0.4167%
LENZ.L $147.00 0%
JPM-PM $19.50 0.3603%
0216.HK $1.23 6.0345%
FRGE.L $35.27 -1.1214%
HIGA-UN $10.04 0%
MJXL $0.39 0%
SBEA $12.01 0%
BXMT $17.09 -1.4137%
ACWX $49.12 -0.7276%
REC.L $85.60 -0.4651%
KXIN $0.30 -3.0596%
AMHCU $10.96 0%
TREI.L $40.72 -0.0184%
TWM $16.82 1.6626%
SMTC.L $1 120.50 -0.004%
KRNLW $0.09 0%
US10.PA $116.40 0.0198%
BRIV3.SA $9.60 0.5236%
GNRC $110.13 -1.6345%
Eng
Логотип
Eng
Лого

Synairgen plc SNG.L

$9.76

+$1.7 (17.46%)
На 18:02, 12 мая 2023

Ранг: 3

Ранг - это оценка кредитоспособности корпорации.

Ключевые показатели

  • Marketcap

    16110001.00000000

  • week52high

    43.98

  • week52low

    7.01

  • Revenue

    0

  • P/E TTM

    -97

  • Beta

    -2.28664100

  • EPS

    -0.11000000

  • Last Dividend

    0.00000000

  • Next Earnings Date

    27 апр 2023 г. в 10:59

Описание компании

Synairgen plc discovers and develops drugs for respiratory diseases. It develops SNG001, an inhaled interferon beta for the treatment of COVID-19; inhaled interferon beta (IFN-ß), which is in Phase-II clinical trials for the treatment of asthma caused by the common cold and flu; IFN-ß that is in Phase-II clinical trials for the treatment or prevention of chronic obstructive pulmonary disease; and LOXL2 inhibitor for the treatment of idiopathic pulmonary fibrosis (IPF) disease. The company has a licensing and collaboration agreement with Pharmaxis Ltd. to develop a LOXL2 inhibitor. Synairgen plc was incorporated in 2004 and is headquartered in Southampton, the United Kingdom.

Свежие комментарии

Оставьте свой голос

Анонимное голосование

Будет ли рост российского рынка к концу года?

  • Да

    87%

  • Нет

    12%

Проголосовал 8 человек